Risk of mortality up to 90 days following uncemented vs cemented total hip arthroplasty for primary osteoarthritis

Alma Pedersen; Aurelie Mailhac; Soren Overgaard; Anne Garland; Ove Furnes; Stein Atle Lie; Anne Marie Fenstad; Cecilia Rogmark; Johan N. Karrholm; Ola Rolfson; Jaason Haapakoski; Antti Eskelinen; Keijo T. Makela; Nils P. Hailer

Risk of mortality up to 90 days following uncemented vs cemented total hip arthroplasty for primary osteoarthritis

Alma Pedersen, Aurelie Mailhac, Soren Overgaard, Anne Garland, Ove Furnes, Stein Atle Lie, Anne Marie Fenstad, Cecilia Rogmark, Johan N. Karrholm, Ola Rolfson, Jaason Haapakoski, Antti Eskelinen, Keijo T. Makela, Nils P. Hailer

Original language	English
Article number	3817
Journal	Pharmacoepidemiology and Drug Safety
Volume	29
Issue number	Suppl. 3
Pages (from-to)	346
Number of pages	1
ISSN	1053-8569
Publication status	Published - Oct 2020
Externally published	Yes
Event	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management - Duration: 16 Sept 2020 → 17 Sept 2020

Conference

Conference	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Period	16/09/2020 → 17/09/2020

Access to Document

https://doi.org/10.1002/pds.5114

Cite this

Pedersen, A., Mailhac, A., Overgaard, S., Garland, A., Furnes, O., Lie, S. A., Fenstad, A. M., Rogmark, C., Karrholm, J. N., Rolfson, O., Haapakoski, J., Eskelinen, A., Makela, K. T., & Hailer, N. P. (2020). Risk of mortality up to 90 days following uncemented vs cemented total hip arthroplasty for primary osteoarthritis. Pharmacoepidemiology and Drug Safety, 29(Suppl. 3), 346. Article 3817. https://doi.org/10.1002/pds.5114

Pedersen, A, Mailhac, A, Overgaard, S, Garland, A, Furnes, O, Lie, SA, Fenstad, AM, Rogmark, C, Karrholm, JN, Rolfson, O, Haapakoski, J, Eskelinen, A, Makela, KT & Hailer, NP 2020, 'Risk of mortality up to 90 days following uncemented vs cemented total hip arthroplasty for primary osteoarthritis', Pharmacoepidemiology and Drug Safety, vol. 29, no. Suppl. 3, 3817, pp. 346. <https://doi.org/10.1002/pds.5114>

@article{1db4f51d0c3f48abb827982d1f3eb49a,

title = "Risk of mortality up to 90 days following uncemented vs cemented total hip arthroplasty for primary osteoarthritis",

author = "Alma Pedersen and Aurelie Mailhac and Soren Overgaard and Anne Garland and Ove Furnes and Lie, \{Stein Atle\} and Fenstad, \{Anne Marie\} and Cecilia Rogmark and Karrholm, \{Johan N.\} and Ola Rolfson and Jaason Haapakoski and Antti Eskelinen and Makela, \{Keijo T.\} and Hailer, \{Nils P.\}",

year = "2020",

month = oct,

language = "English",

volume = "29",

pages = "346",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

number = "Suppl. 3",

note = "36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management ; Conference date: 16-09-2020 Through 17-09-2020",

}

TY - ABST

T1 - Risk of mortality up to 90 days following uncemented vs cemented total hip arthroplasty for primary osteoarthritis

AU - Pedersen, Alma

AU - Mailhac, Aurelie

AU - Overgaard, Soren

AU - Garland, Anne

AU - Furnes, Ove

AU - Lie, Stein Atle

AU - Fenstad, Anne Marie

AU - Rogmark, Cecilia

AU - Karrholm, Johan N.

AU - Rolfson, Ola

AU - Haapakoski, Jaason

AU - Eskelinen, Antti

AU - Makela, Keijo T.

AU - Hailer, Nils P.

PY - 2020/10

Y1 - 2020/10

M3 - Conference abstract in journal

SN - 1053-8569

VL - 29

SP - 346

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - Suppl. 3

M1 - 3817

T2 - 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Y2 - 16 September 2020 through 17 September 2020

ER -